X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.19
Delayed Data
As of Apr 30
 0.00 / 0.00%
Today’s Change
1.55
Today|||52-Week Range
5.00
+10.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues732.1K596.8K387.4K282.3K
 
 
 
 
 
Cost of Goods Sold97.8K139.3K104.0K108.2K
 
 
 
 
 
Depreciation And Amortization81.3K20.3K11.2K10.8K
 
 
 
 
 
 
Operating ExpensesGross Income553.0K437.2K272.2K163.3K
 
 
 
 
 
General Expenses629.2K1.2M865.6K649.3K
 
 
 
 
 
Other Operating Expenses0.000.000.00-0.00
 
 
Research And Development39.1K50.8K40.8K42.3K
 
 
 
 
 
Total Operating Expenses808.3K1.4M980.8K768.3K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-76.2K-765.6K-593.4K-486.0K
 
 
 
 
 
Extraordinary Charge-1.8M---143.8K--
 
 
 
Other Expenses-9.3K-8.1K13.3K-72.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-773.7K-723.9K-558.8K
 
 
 
 
 
Minority Interest-681.7K-76.3K-149.9K-57.1K
 
 
 
 
 
Net Income-1.2M-697.5K-574.0K-501.7K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.3M11.4M11.8M11.9M
 
 
 
 
 
Shares To Calculate EPS Diluted11.3M11.4M11.8M11.9M
 
 
 
 
 
 
Earnings Per ShareEPS---$0.06-$0.04-$0.04
 
 
 
 
EPS Diluted-$0.10-$0.06-$0.04-$0.04
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account